The Maharashtra Public Service Commission (MPSC) has scrapped the recruitment process for Drug Inspectors after a police inquiry confirmed allegations of a paper leak.

  • MPSC cancelled the Group-B Drug Inspector recruitment process.
  • Preliminary police inquiry confirmed prima facie evidence of a paper leak.
  • A fresh examination will be conducted with no new application fees for eligible candidates.

In a major blow to aspirants, the Maharashtra Public Service Commission (MPSC) has officially cancelled the recruitment process for the posts of Drug Inspector (Group-B) within the Food and Drug Administration department. The decision comes in the wake of a preliminary police investigation that uncovered evidence suggesting the question paper was leaked prior to the screening examination held in March 2026.

The recruitment drive had progressed significantly before the cancellation. The screening examination was conducted on March 22, 2026, across six divisional headquarters in Maharashtra. Following the declaration of results on June 12, 506 candidates qualified for the interview stage. Between July 1 and July 22, the Commission had already conducted interviews for 488 candidates and had released a provisional merit list.

Read Also:Former Google Executive Predicts AI Will End Traditional College System Within a Decade

Allegations of Malpractice

The integrity of the examination came under scrutiny following a wave of complaints received by the Commission between July 22 and July 26. Various candidates and public representatives alleged widespread malpractice during the March 22 screening test. The allegations suggested that certain candidates gained unfair advantages by receiving questions via social media and other electronic platforms before the commencement of the exam.

Acting swiftly on these allegations, the MPSC approached the Mumbai Police Commissioner on July 27. A subsequent inquiry by the Deputy Commissioner of the Crime Investigation Branch provided the necessary grounds for cancellation, indicating that at least one candidate had indeed received the paper in advance.

Maintaining the sanctity of public examinations is paramount; a single compromise can erode decades of institutional trust.

Why This Matters: BozokMedia Analysis

BozokMedia analysis shows that this cancellation highlights the persistent vulnerability of state-level recruitment processes to digital leaks. While the decision causes significant delays for hundreds of candidates, it serves as a critical corrective measure to ensure that only the most meritorious individuals enter the state's regulatory framework.

Historical Background

Recruitment scandals have periodically plagued various state commissions across India, leading to increased calls for centralized monitoring and advanced cybersecurity measures in examination conducting bodies. This incident adds to the growing discourse on the need for technological safeguards in competitive exams.

What Happens Next for Candidates?

The Commission has announced that a fresh examination will be organized for the Drug Inspector, Group-B positions. To mitigate the hardship caused by this cancellation, the MPSC has clarified that candidates who were eligible under the previous cycle will not need to re-apply, nor will they be required to pay any additional examination fees. Specific dates and schedules will be announced in a forthcoming notification.

Did You Know?: The Food and Drug Administration (FDA) plays a critical role in ensuring the safety and efficacy of medicines across the state.

Frequently Asked Questions

1. Do I need to submit a new application for the re-examination?
No, eligible candidates from the previous process do not need to re-apply.

2. Will there be any charges for the new exam?
No, the MPSC has confirmed that no examination fee will be charged for the fresh exam.